MedPath

Diffusion-weighted whole-body imaging with background body signal suppression (DWIBS) for colorectal cancer screening: pilot and feasibility study

Withdrawn
Conditions
colon cancer
Colorectal cancer
10017990
10017991
Registration Number
NL-OMON31707
Lead Sponsor
niversitair Medisch Centrum Utrecht
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Withdrawn
Sex
Not specified
Target Recruitment
40
Inclusion Criteria

-Patients with an endoscopically unremovable colorectal tumor, and patients who have undergone a colonoscopy and who do not have a colorectal tumor, in the UMC Utrecht
-Age: 18 years and older
-Written informed consent

Exclusion Criteria

-Patients with a general contraindication for MRI (including cardiovascular pacemakers, claustrophobia)
-Patients who have had a previous malignancy
-Patients who are pregnant or nursing
-Patients in whom therapy has already started

Study & Design

Study Type
Observational non invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>Sensitivity and specificity of DWIBS (with 95% confidence intervals) for the<br /><br>detection of tumors (carcinoma/polyp).</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>N.A.</p><br>
© Copyright 2025. All Rights Reserved by MedPath